Depression in Women: Why It's Twice as Common, Why It's Often Undertreated, and What's Changed

Women are twice as likely as men to experience clinical depression. As many as one in four will have an episode of major depression at some point in their lives. And nearly two-thirds of women with depression don't get the help they need.

That last number is the one worth sitting with. It isn't that women don't recognize something is wrong. It's that the demands of work, caregiving, and relationships leave little room to prioritize it, and that partial relief from a first-line treatment often gets accepted as good enough.

This article covers why depression shows up differently in women, when it tends to strike, and what a woman who has already tried the standard approaches should know about her options now.

The core symptoms are the same across sexes: persistent sad, anxious, or empty mood; loss of interest or pleasure, including in sex; changes in sleep and appetite; fatigue; guilt or worthlessness; trouble concentrating; and in severe cases, thoughts of death. Physical symptoms that don't respond to treatment, like headaches, digestive problems, and chronic pain, are common and often treated separately for years before anyone connects them to mood.

But there are patterns more typical in women:

• Depression tends to start earlier, last longer, and recur more often
• It's more likely to be triggered by stressful life events and to shift with the seasons
• It's more often accompanied by anxiety, especially panic and phobic symptoms
• Guilt is more prominent
• Women attempt suicide more often, though men die by suicide more often

Before puberty, girls and boys have depression at about the same rate. After puberty, a girl's risk doubles. That timing points to hormones, and the pattern continues across a woman's life:

PMS and PMDD. Up to three in four menstruating women have PMS. Three to five percent have PMDD, a severe form marked by depression, anxiety, mood swings, and loss of interest in the week before a period, with dramatic relief once it begins. Disrupted functioning in the brain circuits that regulate mood, combined with hormone fluctuation, is thought to drive it.

Pregnancy. Pregnancy was once assumed to protect against depression. It doesn't. Depression during pregnancy is nearly as common as outside it, and it raises the risk of postpartum depression. Most SSRIs are considered to carry minimal short-term risk in pregnancy, and untreated depression carries real risks of its own.

Postpartum. Treated much like other depression, with medication and therapy, plus newer options developed specifically for the postpartum period.

Perimenopause and menopause. The drop in estrogen in a woman's forties and fifties triggers physical and emotional changes, including depression and anxiety, in many women who never had them before.

Women are more likely than men to be juggling a career, children, and often an aging parent at the same time. That load does two things: it increases the stress that triggers depression, and it removes the time needed to treat it properly.

The typical pattern is a therapist, an SSRI, maybe something for sleep or anxiety layered on top. It helps partly. The woman keeps functioning, so the partial response gets called success, and the dose gets adjusted for years while she operates at 60 percent.

If you've had two or more medication trials and still meet criteria for depression, that has a name: treatment-resistant depression. And the odds that the next medication produces full remission are around 14 percent, after another six to twelve weeks of waiting and side effects.

Antidepressants work on brain chemistry. But depression is also a circuitry problem. The region behind the forehead that regulates mood, motivation, and attention is underactive in depression, and it's the same region implicated in PMDD and perimenopausal mood changes. Medication changes the chemical environment around that circuit. It doesn't directly retrain it.

Transcranial magnetic stimulation (TMS) works on the circuit itself, using focused magnetic pulses through a coil on the scalp. No anesthesia, nothing entering your bloodstream, no systemic side effects: no weight change, no sexual side effects, no interaction with other medications. Brain stimulation is already recognized as an option for severe depression in women when other treatments haven't worked.

SAINT (Stanford Accelerated Intelligent Neuromodulation Therapy) is an accelerated, FDA-cleared form of TMS developed at Stanford's Brain Stimulation Lab. It's cleared for adults with major depressive disorder who haven't gotten adequate relief from antidepressants in their current episode.

For a woman with a full life, the schedule is the difference. Standard TMS is one session a day for six to nine weeks, 30 to 36 visits. SAINT is five days. Here's how it works at a Verified SAINT Provider like Neuro Wellness TMS Centers of America:

1. Consultation. Our clinical team reviews your history, your medication trials, and your current symptoms, and confirms you're a candidate. The initial consultation is a Zoom call; as steps evolve, you'll also have the option to meet with our psychiatrist by Zoom web conference or in person. The mandatory in-person steps include fMRI mapping and the actual treatment.
2. fMRI brain scan. A roughly 45-minute functional MRI maps how your individual brain networks are wired.
3. Personalized targeting. A targeting algorithm reads your scan and identifies the exact location for stimulation. Neuronavigation guides the coil there for every session.
4. Five-day stimulation series. Ten 10-minute sessions per day, with 50-minute breaks in between, for five consecutive days. One arranged week, not two months of daily appointments.

In the clinical trials behind SAINT's clearance, 79 percent of participants reached remission, with an average time to remission of 2.6 days. Across more than 400 trial patients, 85 percent experienced symptom relief, with no serious adverse events. Side effects were generally mild: headache, fatigue, and temporary scalp discomfort. SAINT isn't appropriate for people with non-removable metal in or near the head or an implanted device. You don't have to stop your current medications.

One honest note: SAINT has not been specifically studied in pregnancy. If you're pregnant or planning to be, that's a conversation for your consultation and your OB.

You are allowed to want more than functioning. If you've spent years getting everyone else to their appointments while managing your own depression around the edges, one week focused on your own recovery is not indulgent. It may be the thing that gives you back the capacity for everything else.

At Neuro Wellness TMS Centers of America, the first appointment is an evaluation, not a commitment. We offer private outpatient care with a dedicated care team and weekend availability. We'll review your history and tell you honestly whether SAINT is a fit. Insurance coverage varies by plan; our team can help you understand your options, including prior authorization and self-pay.

Schedule a consultation: 954-827-9793

If you are in crisis or thinking about harming yourself, call or text 988 (Suicide & Crisis Lifeline) or go to your nearest emergency room. This article is for educational purposes and is not a substitute for individual medical advice.